{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-379420","form_type":"8-K","ticker":"DH","cik":"0001861795","company_name":"Definitive Healthcare Corp.","filed_at":"2026-09-02T12:31:13+00:00","discovered_at":"2026-09-02T12:36:03.645031+00:00","generated_at":"2026-09-02T12:36:12.847953+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Definitive Healthcare names Clay Ritchey CEO; Kevin Coop steps down","bullets":["Clay Ritchey named CEO and board member effective Sept 8, 2026; Kevin Coop departed Aug 31, 2026.","Employment terms: $500k base salary, 87.5% target bonus, $4M equity grant (65% time-based, 35% performance-based).","Ritchey previously CEO of Verato (2021-2026), Evariant, and Equinox; brings 25+ years healthcare tech experience.","Coop's departure not due to disagreement; separation agreement to be filed later.","Company cites upcoming AI-powered platform as growth catalyst under new CEO."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-379420","json":"https://secwatch.observer/filing/0001193125-26-379420.json","markdown":"https://secwatch.observer/filing/0001193125-26-379420.md","text":"https://secwatch.observer/filing/0001193125-26-379420.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861795/000119312526379420/0001193125-26-379420-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861795/000119312526379420/dh-20260828.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-02T12:36:12.847953+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}